论文信息 - Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic - 字舞流文

Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic

J. Satsangi | P. Klenerman | R. Sadler | S. Travis | J. Lindsay | O. Brain | T. Ambrose | C. Arancibia-Cárcamo | N. Croft | A. Walsh | A. Adams | R. Palmer | C. McGregor